Opinion statement
Peripheral artery disease (PAD) creates a significant national and international healthcare burden. A first line treatment for PAD is supervised walking exercise in hospitals and clinics. Specifically, supervised walking exercise seeks to improve the classic symptom associated with PAD, intermittent claudication (IC), which is characterized by cramping, aching and pain of the muscles in the lower extremities during walking. While effective, supervised walking exercise is often not prescribed or utilized due to a number of treatment barriers such as lack of transportation to clinical centers and lack of insurance reimbursement. Walking exercise in community settings is an option that has gained attention due to the limitations of supervised walking exercise, as community walking is generally more convenient in terms of a patient’s schedule and may circumvent potential barriers such as treatment cost and transportation difficulties. However, more research is needed to improve the effectiveness of community-based walking programs since far less is known about the optimal structure of such programs. Other exercise therapy options are becoming available for PAD patients in addition to walking exercise. These modalities include but are not limited to leg and arm ergometry, polestriding and resistance training. These exercise therapy options have not to date been as well validated as supervised walking exercise. However, they may potentially be used in the event supervised walking exercise is not feasible or patient preference warrants an alternative exercise strategy.
Keywords: Peripheral Artery Disease, Walking Exercise, Physical Activity, Supervised Training, Community-Based Exercise, Polestriding, Cycle Ergometry, Arm Ergometry, Strength Training, Plantar Flexion, Quality Of Life, Patient-Reported Outcomes
Introduction
It is estimated that peripheral artery disease (PAD) affects up to 10% of the worldwide population and the prevalence increases to as high as 20% among patients 70 years of age and older [1–4]. Atherosclerotic PAD is characterized by significant narrowing of the arteries in the legs due to the development of plaque. The stenoses and/or occlusions of the peripheral arteries lead to decreased blood flow to the muscles of the legs resulting in a range of leg symptoms. The severity of the associated symptoms are highly variable and range from complete lack of symptoms, to atypical symptoms, to leg pain with exertion, and finally to the most severe form, critical limb ischemia (CLI), which is characterized by rest pain in the legs and feet as well as potential tissue and limb loss [5–7]. For patients with mild and moderate levels of PAD, the primary symptom often reported is intermittent claudication (IC), described as pain, aching, fatigue and/or cramps in the calves, thighs and/or buttocks which is induced by walking and relieved by rest [4]. Thus, individuals with IC are often sedentary and may avoid most forms of ambulation. This behavior ultimately decreases functional capacity, leading to poor patient-reported outcomes which are strongly associated with an increased risk of premature mortality [8].
A primary treatment option for PAD patients with IC, and often considered the gold standard therapy, is a program of supervised walking exercise training which is typically a 3 month program performed in a hospital or healthcare clinic [9,10]. These programs consist of intermittent bouts of walking interspersed with periods of rest when moderate to severe leg pain manifests [11]. A supervised exercise program typically improves overall walking ability by allowing the PAD patient to walk for longer periods of time and by increasing distance and/or time at which claudication symptoms first appear while walking [12,13]. However, supervised exercise programs are underutilized possibly due to lack of reimbursement from insurance companies, a lack of local training centers, and the need for PAD patients to travel to a facility frequently over an extended period of time. Thus community walking programs have recently gained attention as a potential option for treating IC. Using the patient’s living environment may be a valid setting in which to promote walking exercise. However, the effectiveness of this type of program for improving PAD patients’ walking ability has not been well established [14]. Given the current state of the US healthcare system for treating PAD (i.e., lack of reimbursement for supervised training), development of exercise programs conducted in the community setting merits more attention. However, the design of these programs has not been standardized as with supervised exercise programs. Often, researchers (and clinicians) have just recommended that patients with PAD “go home and walk.” Such studies have not generally resulted in significant improvement in walking ability and patient-reported outcomes. More recently, there have been better designed studies that provide more effective ways of getting patients to exercise in the community. Specifically programs using established supervised walking guidelines that monitor PAD patients in the community over the course of an intervention and provide direct feedback on how to improve walking ability may be beneficial.
There are a number of other exercise based methods for treating IC in addition to walking programs. Therapies under development primarily consist of using different modes of exercise including: 1) leg ergometry and arm ergometry, 2) polestriding and 3) resistance training. The evidence is not as robust for improving health outcomes using these modalities as it is for supervised exercise, at least in part because they have only been recently developed. However, there may be instances where these alternative exercise therapies merit usage in the clinical setting or if patient preference warrants their use, for example, using arm ergometry exercise for PAD patients who are unable to walk, such as among those with toe or lower limb amputation. The purpose of this review is to evaluate the current literature for exercise therapy to treat PAD patients. Table 1 provides a brief review of the advantages and disadvantages of each type of exercise therapy available for patients with PAD and IC.
Table 1.
Exercise Modality | Advantages | Disadvantages |
---|---|---|
supervised walking |
|
|
community walking |
|
|
leg ergometry |
|
|
arm ergometry |
|
|
polestriding |
|
|
resistance training |
|
|
ACC American College of Cardiology; AHA American Heart Association; CLI critical limb ischemia; COT claudication onset time; IC intermittent claudication; PAD peripheral artery disease; PWT peak walking time
TREATMENT
The goals of exercise therapy for PAD patients should, in most cases, be to improve walking ability, with the most common endpoint assessed being peak walking time (PWT) or peak walking distance, as well as claudication onset time (COT) or claudication onset distance. Other pertinent outcomes for evaluating impact of exercise among PAD patients include patient-reported outcomes assessed by questionnaires such as the disease-specific Walking Impairment Questionnaire (WIQ) or the Medical Outcomes Study 36-item short form questionnaire (SF-36), a quality of life measure [15,16]. Although all types of exercise are beneficial for general cardiovascular health, supervised walking has been preferred for PAD patients and will result in physiological adaptations specifically leading to improvement in walking outcomes.
Exercise therapy for claudication
Supervised walking exercise
Supervised walking exercise has been well validated as an effective treatment for walking impairment due to PAD [4,11,17]. Supervised walking in hospitals and health-care clinics is considered the gold standard (IA) treatment for patients with PAD and IC according to the ACC/AHA practice guidelines for the management of PAD [9]. In a meta-analysis of randomized controlled trials, Watson et al. [18] concluded that supervised exercise training improved PWT of PAD patients who experienced IC by 50–200%. Patient-reported outcomes have been shown to improve as well [17,19], which is important as the patient’s perception of health following treatment may guide therapy decisions. Additionally, exercise training improves the cardiovascular system and risk factors as well as local skeletal muscle adaptations [12,13,20] indicating this type of therapy as a primary option for PAD patients.
Recently, the multicenter Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial evaluated the primary outcome of PWT for PAD patients with IC randomized into 3 separate groups: 1) supervised walking plus optimal medical therapy, 2) endovascular revascularization plus optimal medical therapy and 3) optimal medical therapy alone [17]. Results indicated that at the 6 month follow-up time point, the primary endpoint of PWT improved the most in the supervised walking group compared to revascularization and optimal medical therapy alone (+5.8 vs. +3.7 vs. +1.2 minutes). COT values improved similarly in the supervised walking group and revascularization group and both were higher than optimal medical therapy group patient outcomes (+3.0 vs. +3.6 vs. +0.7 minutes). Disease-specific patient-reported outcomes assessed by the WIQ and Peripheral Artery Questionnaire [21] improved in both the supervised walking and revascularization treatment groups with the greatest improvements in the revascularization group.
Usage
Patients typically walk on a motorized treadmill until limited by the development of moderate IC (3 or 4 on the Claudication Symptom Rating Scale which ranges from 1 = no pain to 5 = severe pain). Each bout of walking is then followed by a rest period to allow the leg pain to subside after which the patient resumes walking. The walking/rest sessions continue until the patient reaches 35 to 50 minutes of total combined time, and completes at least three sessions∙week−1, for a total duration of 3 to 6 months. However, recently, Gardner et al. [22] found that adherence rates may in fact be better with programs that are only 2 months in duration.
Special points
It is not uncommon for patients to continue having residual claudication following revascularization [23] potentially due to initial sub-optimal clinical success rates (e.g., patency), restenosis, multi-vessel disease, or new symptoms in the opposing leg if bilateral revascularization was not performed. However, for patients where IC has resolved, ratings of perceived exertion (RPE) using the Borg 15 Category RPE Scale or OMNI Perceived Exertion Scales can be used to regulate exercise intensity at a moderately hard level [24,25], which has been used successfully in previous exercise training programs for asymptomatic PAD patients [26]. This method may be a better alternative to using moderate intensity prescriptions based on age-predicted exercise heart rate responses as many PAD patients are prescribed medications (e.g., beta-blockers) that may affect heart rate during exercise.
Cost/cost-effectiveness
Treesak et al. [27] examined cost-effectiveness of 3 and 6 months of supervised exercise training and endovascular therapy in patients who experienced claudication. Findings indicated that at 3 months, endovascular therapy was more effective clinically than exercise training as evidenced by improvements in peak walking distance [27]. However, outcomes at 6 months indicated that exercise training provided more gains in walking distance (137 meters) and less cost per meter gained ($61 less) than endovascular therapy.
Community-based walking exercise
Studies employing general advice by physicians and healthcare providers to exercise have proven largely ineffective for PAD patients, and patients given this advice have often served as the control group in clinical trials [28–30]. A meta-analysis of supervised exercise programs and unsupervised exercise programs in home and community settings revealed that supervised exercise therapy has a far greater clinical benefit compared with non-supervised community regimens [14]. However, recent studies have begun to emerge using more intensive structured interventional components in settings outside of clinics to create more effective programs in the community. Gardner et al. [31] conducted a 12 week intervention employing supervised exercise training, community exercise training and a non-exercising control arm for patients with IC. Compliance to exercise was monitored with a piezoelectric activity monitor for the supervised exercise group and the community exercise group. Patients were also asked to complete diaries/log books outlining the exercise sessions. The exercise program for the community exercise group consisted of intermittent walking to near-maximal leg pain for 3 days per week. Patients walked and rested initially for 20 minutes over a 2 week period and periodically increased duration by 5 minutes until a total of 45 minutes of walking was reached. Positive improvements for COT and PWT were demonstrated for the supervised exercise group (+165 and +215 seconds, P < .001) and the community exercise group (+134 and +124 seconds, P < .01) but not for the control group (−16 and −10 seconds). Additionally, patient-reported outcomes assessed with the WIQ and SF-36 both improved for patients in the supervised and community exercise groups but not for the non-exercising control group. Thus there is evidence that structured community exercise programs can be effective.
Usage
Exercise prescription components (duration, intensity, frequency of exercise) for community-based walking exercise should be methodologically similar to supervised exercise programs.
Special points
A limiting factor of community exercise program implementation is that although the established, peer-reviewed guidelines of supervised exercise programs may be prescribed to patients, they may not be feasibly applied in the typical community setting. For example, when a patient experiences IC in the community while walking, there may not be an adequate place to sit and rest. Additionally, issues related to the built environment (e.g., lack of or poor quality sidewalks), weather, and crime/safety concerns may prevent patients from walking in the community for an extended period of time. Thus, this type of therapy for PAD patients is still evolving and warrants additional research.
Cost/cost-effectiveness
A recent Dutch study evaluated the cost-effectiveness of supervised exercise compared to exercise advice without supervision [32]. Findings indicated that the supervised exercise program was more effective (more costly as well) than the exercise advice program for PAD patients. These findings are not surprising, given the ineffectiveness of unsupervised community walking programs where only advice is given to patients. Cost-effectiveness data have not been evaluated with regard to the more recently developed community based exercise programs which feature some elements of supervised exercise in the community setting.
Leg ergometry
PAD patients with IC have pronounced gait alterations [33] and may have comorbidities such as obesity and other factors that confound walking which may make leg ergometer usage an attractive alternative form of exercise. A number of studies have demonstrated leg ergometry to be an effective approach for improving walking and/or cycling outcomes for PAD patients [34–37]. Additionally, Tuner et al. [38] evaluated absolute claudication time and cardiorespiratory outcomes during incremental cycling and treadmill exercise testing in a group of PAD patients with IC. Results indicated similar absolute claudication time outcomes between the two modalities in addition to significantly higher cardiovascular and metabolic responses during leg ergometry compared to treadmill walking. These findings provide additional support for the use of leg ergometry as it employs functional usage of the lower limbs resulting in specificity to training, inducing both central as well as peripheral vascular and metabolic adaptations. Thus leg ergometry may be a valid approach to improving walking ability for PAD patients although more research is needed to establish the role of this newer therapy for IC.
Usage
Studies using leg ergometry as a treatment modality for PAD patients have generally used similar exercise prescription methods as supervised walking exercise, that is, patients exercise for several minutes to the point of moderate pain then follow with several minutes of rest until a pre-defined exercise/rest duration is reached for each session [34,36,37].
Special points
Leg ergometry seating may be uncomfortable for patients. This may represent a barrier to participating in this type of exercise.
Cost/cost-effectiveness
To date there are no cost-effectiveness studies available for leg ergometer exercise for PAD patients with IC.
Arm ergometry
For those patients who are unable to perform leg exercise such as patients with lower limb amputations or CLI, arm ergometry may be a valid approach for treatment and a number of trials have examined its usage for improving walking ability for patients with IC [35–37,39–41]. In a more recent trial using arm ergometry to treat PAD patients with claudication, Bronas et al. [40] found a significant change in claudication onset distance from baseline to 12 weeks for patients completing an arm ergometer exercise program (+89.6 meters, P < .01) which was also similar to patients in a supervised walking program (+106.7 meters) and higher among control patients (+7.3 meters). Additionally, there were no differences in peak walking distances for patients randomized to the arm ergometer exercise program (+181.1 meters) vs. the supervised walking program group (+297.6 meters) but both intervention groups showed more improvement than control patients (+46.3 meters, P < .05). These findings are critically important for establishing upper limb exercise as an alternative therapy for PAD patients, as a major barrier to walking exercise is IC.
Usage
Methods for several studies [39,40] have had patients starting at a cadence of 50 revolutions∙min−1 and 10 W below maximal output achieved during an arm ergometer exercise test. Because patients are not using their lower limbs during arm ergometry and may not experience IC, patients exercise for 2 minutes using an exercise intensity range of 13–15 on the Borg 15 Category Ratings of Perceived Exertion scale. This is followed by 2 minutes of rest for a total duration of 60 minutes and is similar to the walk/rest ratio used for supervised walking exercise programs. The duration of the exercise portion of the overall session is increased every few weeks with up to 5 minutes of exercise interspersed with 1 minute of rest.
Special points
This type of exercise, while promising, still currently requires supervised support by healthcare providers thus lending itself to the same limitations as supervised walking exercise such as lack of reimbursement for supervision and the need for patients to travel to and attend clinic visits for an extended period of time.
Cost/cost-effectiveness
No studies have addressed cost-effectiveness of arm ergometry for patients with IC.
Polestriding
Polestriding is a type of exercise where patients ambulate with poles for additional upper body motion thereby increasing the central cardiovascular demand. The use of polestriding for treating PAD is intended to elicit a cardiorespiratory response that may not be possible in all patients such as those with severe IC, as the poles used during walking attenuate lower limb pain by redistributing weight to the poles in addition to decreasing the vertical ground reaction forces during walking [42,43]. While there are only a few studies examining this modality for use in PAD, results are promising for treating IC [43–47]. In a sample of n = 77 PAD patients who completed 24 weeks of training, Collins et al. [47] examined the effect on walking ability of polestriding vs. supervised walking. The change in PWT for the supervised walking group at 24 weeks was higher compared to the polestriding group, however the difference was not statistically significant (+170 vs. +127%). Additionally, adherence to exercise sessions over the course of the intervention was similar between groups (polestriding: 73 ± 24 and supervised walking: 73 ± 22%). Thus, polestriding may be a viable alternative to standard walking programs, however, large scale multicenter trials are needed to establish this therapy as a primary treatment for IC.
Usage
According to the recent study by Collins et al. [47], patients exercised initially for 3 times∙week−1 for 30 minutes at light, moderate and high intensities. Intensity of exercise was based on percentages of maximal heart rate achieved from an initial walking treadmill test. The majority of the exercise time occurred at a moderate intensity of 60% of time, compared to 20% each at light and high intensities. The goal was to complete 60 minutes of exercise by the end of the intervention at the following intensities: 1) light intensity for 10% of total time, 2) moderate intensity for 35% of total time, 3) high intensity at 50% of total time, and 4) very high intensity for 5% of total time.
Special points
Patients may need an extensive familiarization session for polestriding exercise as the movement may be difficult initially.
Cost/cost-effectiveness
Not studied
Resistance training
Resistance training is comprised of several different types of exercise including plantar flexion and upper and/or lower body endurance and strength training. Plantar flexion exercise consists of patients being in a seated or recumbent position and actively moving the foot in a plantar and dorsi flexion motion against a resistive pedal. Several trials have examined this mode of exercise for improving walking ability in PAD [48–50]. Recently, Tebbutt et al. [48] randomized PAD patients (n = 42) to an unsupervised intervention group consisting of 12 weeks of plantar flexion (also advice to walk at home) and a control group that received only advice to walk at home. Results indicated an improvement in median claudication onset distance and peak walking distance for patients enrolled in the intervention group (+20 and +40 meters) but not for those in the control group (+0 and −50 meters). However, it should be noted that the study was discontinued prematurely, resulting in an interim analysis that determined the variance of outcomes were too high and thus significant differences were not found. Although a considerable amount of research is needed to determine the effectiveness and successful implementation of plantar flexion exercise, this recent study is promising as this type of modality does bypass barriers to walking exercise. For example, in patients with orthopedic issues such as knee arthritis, this could be an option as the knee joint is not involved directly in moving the resistive pedal. However, in the event of iliac arterial disease, where the patient may experience buttock claudication with ambulation, this modality may not be an optimal treatment option.
Other resistance training studies have evaluated the effect of strength training consisting of dynamic movement using the upper and/or lower limbs to determine if walking ability is improved in PAD patients [13,26,50–55]. Recently, Meneses et al. [52] compared the effects on claudication onset distance and peak walking distance following a supervised upper and lower body resistance exercise program or a supervised walking program in patients with IC. There were significant improvements in walking ability pre and post intervention for both the resistance training group (claudication onset distance: +182 meters, P < .01; peak walking distance: +172 meters, P < .001) and the supervised walking group (claudication onset distance: +132 meters, P < .01; peak walking distance: +173 meters, P < .001) but no differences were observed between groups. McDermott et al. [26] found that a 6 month lower extremity resistance training program for patients with and without IC significantly improved PWT compared to patients randomized to a control group (+2.41 vs. +0.51 minutes, P = .009). Additionally, the resistance training group demonstrated greater median improvements compared to the control group for the physical component score of the SF-36 (+10.0 vs. +5.0, P = .04) as well as WIQ distance scores (+8.52 vs. +0.25, P = .03) and stair climbing scores (+12.5 vs. +0.0, P = .02). Thus, these studies as well as the others cited demonstrate resistance training to be a potentially useful mode of exercise for PAD patients.
Usage
The methods for the few studies examining plantar flexion exercise for improving walking ability in PAD and IC generally consists of one leg performing exercise at a given time, with patients exercising and then resting which is similar to the walk/rest concept used in supervised walking exercise. For dynamic strength training, exercise prescription methods are variable and dependent on the desired outcome (maximal strength gains vs. muscular endurance improvement), although many studies have used a standard exercise prescription consisting of 2 or 3 sets, ranging from 5 to 30 repetitions with several minutes of rest in between sets and using RPE to regulate exercise intensity [26,51,52].
Special points
The cardiovascular system may not be impacted to as great an extent as seen in walking programs. Thus resistance exercise may be used as a complementary part of the exercise prescription given that the cardiovascular system is adversely effected in PAD.
Cost/cost-effectiveness
Resistance training for PAD has not been studied directly or in comparison with other treatments with regard to cost or cost-effectiveness. However an early study in assessing the effectiveness of resistance training to improve walking ability of PAD patients concluded that the modest benefits demonstrated could not allow for a recommendation that resistance training is a cost-effective approach for treating PAD and IC [13].
Footnotes
Disclosure
No potential conflicts of interest relevant to this article were reported.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as:
• Of importance
•• Of major importance
- 1.Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71(3):510–515. doi: 10.1161/01.cir.71.3.510. [DOI] [PubMed] [Google Scholar]
- 2.Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley diabetes study. Circulation. 1995;91(5):1472–1479. doi: 10.1161/01.cir.91.5.1472. [DOI] [PubMed] [Google Scholar]
- 3.Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the national health and nutrition examination survey, 1999–2000. Circulation. 2004;110(6):738–743. doi: 10.1161/01.CIR.0000137913.26087.F0. [DOI] [PubMed] [Google Scholar]
- 4.Norgren L, Hiatt WR, Dormandy JA, et al. Intersociety consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg. 2007;45(Suppl S):S5–S67. doi: 10.1016/j.jvs.2006.12.037. [DOI] [PubMed] [Google Scholar]
- 5.McDermott MM, Mehta S, Greenland P. Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease. Arch Intern Med. 1999;159(4):387–392. doi: 10.1001/archinte.159.4.387. [DOI] [PubMed] [Google Scholar]
- 6.Olin JW, Sealove BA. Peripheral artery disease: Current insight into the disease and its diagnosis and management. Mayo Clin Proc. 2010;85(7):678–692. doi: 10.4065/mcp.2010.0133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Lyden SP, Joseph D. The clinical presentation of peripheral arterial disease and guidance for early recognition. Cleve Clin J Med. 2006;73(Suppl 4):S15–S21. doi: 10.3949/ccjm.73.suppl_4.s15. [DOI] [PubMed] [Google Scholar]
- 8.Issa SM, Hoeks SE, Scholte op Reimer WJM, et al. Health-related quality of life predicts long-term survival in patients with peripheral artery disease. Vasc Med. 2010;15(3):163–169. doi: 10.1177/1358863X10364208. [DOI] [PubMed] [Google Scholar]
- 9.Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): Executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Transatlantic Inter-society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006;47(6):1239–1312. doi: 10.1016/j.jacc.2005.10.009. [DOI] [PubMed] [Google Scholar]
- 10.Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the management of peripheral arterial disease (TASC II) Eur J Vasc Endovasc Surg. 2007;33(Suppl 1):S1–S75. doi: 10.1016/j.ejvs.2006.09.024. [DOI] [PubMed] [Google Scholar]
- 11.Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA. 1995;274(12):975–980. [PubMed] [Google Scholar]
- 12.Hiatt WR, Regensteiner JG, Hargarten ME, et al. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation. 1990;81(2):602–609. doi: 10.1161/01.cir.81.2.602. [DOI] [PubMed] [Google Scholar]
- 13.Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response. Circulation. 1994;90(4):1866–1874. doi: 10.1161/01.cir.90.4.1866. [DOI] [PubMed] [Google Scholar]
- 14.Bendermacher BL, Willigendael EM, Teijink JA, Prins MH. Supervised exercise therapy versus nonsupervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev. 2006;(2):CD005263. doi: 10.1002/14651858.CD005263.pub2. [DOI] [PubMed] [Google Scholar]
- 15.Regensteiner JG, Steiner JF, Panzer RJ, Hiatt WR. Evaluation of walking impairment by questionniare in patients with peripheral artery disease. J Vasc Med Biol. 1990;2:142–152. [Google Scholar]
- 16.Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483. [PubMed] [Google Scholar]
- 17. Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: Six-month outcomes from the claudication: Exercise versus endoluminal revascularization (CLEVER) study. Circulation. 2012;125:130–139. doi: 10.1161/CIRCULATIONAHA.111.075770.. This study was a multicenter randomized controlled trial comparing key walking outcomes in PAD patients following supervised exercise, endovascular revascularization and optimal medical therapy.
- 18.Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2008;(4):CD000990. doi: 10.1002/14651858.CD000990.pub2. [DOI] [PubMed] [Google Scholar]
- 19. Kruidenier LM, Viechtbauer W, Nicolai SP, et al. Treatment for intermittent claudication and the effects on walking distance and quality of life. Vascular. 2012;20(1):20–35. doi: 10.1258/vasc.2011.ra0048. This meta-anlaysis evaluated effectiveness of supervised exercise, angioplasty, surgery and no treatment on walking ability and quality of life in PAD patients. While each intervention improved patient outcomes, a sensitivity analysis determined that only supervised exercise had significant value over no treatment.
- 20.Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med. 2002;347(24):1941–1951. doi: 10.1056/NEJMra021135. [DOI] [PubMed] [Google Scholar]
- 21.Spertus J, Jones P, Poler S, Rocha-Singh K. The peripheral artery questionnaire: A new diseasespecific health status measure for patients with peripheral arterial disease. Am Heart J. 2004;147(2):301–308. doi: 10.1016/j.ahj.2003.08.001. [DOI] [PubMed] [Google Scholar]
- 22. Gardner AW, Montgomery PS, Parker DE. Optimal exercise program length for patients with claudication. J Vasc Surg. 2012;55(5):1346–1354. doi: 10.1016/j.jvs.2011.11.123. The study determined that 2 months of supervised walking improved COT and PWT for PAD patients with IC and outcomes were maintained with additional training. Thus shorter duration walking programs may be preferred as adherence rates are higher and costs are lower.
- 23.Spronk S, Bosch JL, den Hoed PT, et al. Intermittent claudication: Clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training--randomized controlled trial. Radiology. 2009;250(2):586–595. doi: 10.1148/radiol.2501080607. [DOI] [PubMed] [Google Scholar]
- 24.Borg G. An Introduction to Borg's RPE-scale. Ithaca, NY: Mouvement; 1985. [Google Scholar]
- 25.Robertson RJ. Perceived Exertion for Practitioners: Rating Effort with the OMNI Picture System. Champaign, IL: Human Kinetics; 2004. [Google Scholar]
- 26.McDermott MM, Ades P, Guralnik JM, et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: A randomized controlled trial. JAMA. 2009;301(2):165–174. doi: 10.1001/jama.2008.962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Treesak C, Kasemsup V, Treat-Jacobson D, et al. Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease. Vasc Med. 2004;9(4):279–285. doi: 10.1191/1358863x04vm570oa. [DOI] [PubMed] [Google Scholar]
- 28.Kakkos SK, Geroulakos G, Nicolaides AN. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: A randomised controlled trial. Eur J Vasc Endovasc Surg. 2005;30(2):164–175. doi: 10.1016/j.ejvs.2005.03.011. [DOI] [PubMed] [Google Scholar]
- 29.Nicolai SP, Teijink JA, Prins MH. Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication. J Vasc Surg. 2010;52(2):348–355. doi: 10.1016/j.jvs.2010.02.022. [DOI] [PubMed] [Google Scholar]
- 30.Allen JD, Stabler T, Kenjale A, et al. Plasma nitrite flux predicts exercise performance in peripheral arterial disease after 3 months of exercise training. Free Radic Biol Med. 2010;49(6):1138–1144. doi: 10.1016/j.freeradbiomed.2010.06.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Gardner AW, Parker DE, Montgomery PS, et al. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: A randomized controlled trial. Circulation. 2011;123(5):491–498. doi: 10.1161/CIRCULATIONAHA.110.963066.. This trial determined that community-based exercise programs with more intensive monitoring and feedback by investigators was beneficial for PAD patients with IC.
- 32.van Asselt AD, Nicolai SP, Joore MA, et al. Cost-effectiveness of exercise therapy in patients with intermittent claudication: Supervised exercise therapy versus a 'go home and walk' advice. Eur J Vasc Endovasc Surg. 2011;41(1):97–103. doi: 10.1016/j.ejvs.2010.06.024. [DOI] [PubMed] [Google Scholar]
- 33.Gardner AW, Montgomery PS, Ritti-Dias RM, Forrester L. The effect of claudication pain on temporal and spatial gait measures during self-paced ambulation. Vasc Med. 2010;15(1):21–26. doi: 10.1177/1358863X09106836. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Sanderson B, Askew C, Stewart I, et al. Short-term effects of cycle and treadmill training on exercise tolerance in peripheral arterial disease. J Vasc Surg. 2006;44(1):119–127. doi: 10.1016/j.jvs.2006.03.037. [DOI] [PubMed] [Google Scholar]
- 35.Walker RD, Nawaz S, Wilkinson CH, et al. Influence of upper- and lower-limb exercise training on cardiovascular function and walking distances in patients with intermittent claudication. J Vasc Surg. 2000;31(4):662–669. doi: 10.1067/mva.2000.104104. [DOI] [PubMed] [Google Scholar]
- 36.Saxton JM, Zwierska I, Blagojevic M, et al. Upper-versus lower-limb aerobic exercise training on health-related quality of life in patients with symptomatic peripheral arterial disease. J Vasc Surg. 2011;53(5):1265–1273. doi: 10.1016/j.jvs.2010.10.125. [DOI] [PubMed] [Google Scholar]
- 37.Zwierska I, Walker RD, Choksy SA, et al. Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: A randomized controlled trial. J Vasc Surg. 2005;42(6):1122–1130. doi: 10.1016/j.jvs.2005.08.021. [DOI] [PubMed] [Google Scholar]
- 38.Tuner SL, Easton C, Wilson J, et al. Cardiopulmonary responses to treadmill and cycle ergometry exercise in patients with peripheral vascular disease. J Vasc Surg. 2008;47(1):123–130. doi: 10.1016/j.jvs.2007.09.001. [DOI] [PubMed] [Google Scholar]
- 39.Treat-Jacobson D, Bronas UG, Leon AS. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication. Vasc Med. 2009;14(3):203–213. doi: 10.1177/1358863X08101858. [DOI] [PubMed] [Google Scholar]
- 40. Bronas UG, Treat-Jacobson D, Leon AS. Comparison of the effect of upper body-ergometry aerobic training vs treadmill training on central cardiorespiratory improvement and walking distance in patients with claudication. J Vasc Surg. 2011;53(6):1557–1564. doi: 10.1016/j.jvs.2011.01.077.. This study provided evidence that cardiorespiratory improvements following arm ergometry exercise for PAD patients were significantly associated with walking outcomes.
- 41.Tew G, Nawaz S, Zwierska I, Saxton JM. Limb-specific and cross-transfer effects of arm-crank exercise training in patients with symptomatic peripheral arterial disease. Clin Sci. 2009;117(12):405–413. doi: 10.1042/CS20080688. [DOI] [PubMed] [Google Scholar]
- 42.Willson J, Torry MR, Decker MJ, et al. Effects of walking poles on lower extremity gait mechanics. Med Sci Sports Exerc. 2001;33(1):142–147. doi: 10.1097/00005768-200101000-00021. [DOI] [PubMed] [Google Scholar]
- 43.Collins EG, Langbein WE, Orebaugh C, et al. Cardiovascular training effect associated with polestriding exercise in patients with peripheral arterial disease. J Cardiovasc Nurs. 2005;20(3):177–185. doi: 10.1097/00005082-200505000-00009. [DOI] [PubMed] [Google Scholar]
- 44.Collins EG, Edwin Langbein W, Orebaugh C, et al. Polestriding exercise and vitamin E for management of peripheral vascular disease. Med Sci Sports Exerc. 2003;35(3):384–393. doi: 10.1249/01.MSS.0000053658.82687.FF. [DOI] [PubMed] [Google Scholar]
- 45.Langbein WE, Collins EG, Orebaugh C, et al. Increasing exercise tolerance of persons limited by claudication pain using polestriding. J Vasc Surg. 2002;35(5):887–893. doi: 10.1067/mva.2002.123756. [DOI] [PubMed] [Google Scholar]
- 46.Oakley C, Zwierska I, Tew G, et al. Nordic poles immediately improve walking distance in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2008;36(6):689–694. doi: 10.1016/j.ejvs.2008.06.036. [DOI] [PubMed] [Google Scholar]
- 47.Collins EG, O'Connell S, McBurney C, et al. Comparison of walking with poles and traditional walking for peripheral arterial disease rehabilitation. J Cardiopulm Rehabil Prev. 2012;32(4):210–218. doi: 10.1097/HCR.0b013e31825828f4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Tebbutt N, Robinson L, Todhunter J, Jonker L. A plantar flexion device exercise programme for patients with peripheral arterial disease: A randomised prospective feasibility study. Physiotherapy. 2011;97(3):244–249. doi: 10.1016/j.physio.2010.08.009. [DOI] [PubMed] [Google Scholar]
- 49.Wang E, Hoff J, Loe H, et al. Plantar flexion: An effective training for peripheral arterial disease. Eur J Appl Physiol. 2008;104(4):749–756. doi: 10.1007/s00421-008-0826-3. [DOI] [PubMed] [Google Scholar]
- 50.Mosti MP, Wang E, Wiggen ON, et al. Concurrent strength and endurance training improves physical capacity in patients with peripheral arterial disease. Scand J Med Sci Sports. 2011;21(6):e308–e314. doi: 10.1111/j.1600-0838.2011.01294.x. [DOI] [PubMed] [Google Scholar]
- 51.McGuigan MR, Bronks R, Newton RU, et al. Resistance training in patients with peripheral arterial disease: Effects on myosin isoforms, fiber type distribution, and capillary supply to skeletal muscle. J Gerontol A Biol Sci Med Sci. 2001;56(7):B302–B310. doi: 10.1093/gerona/56.7.b302. [DOI] [PubMed] [Google Scholar]
- 52.Meneses AL, de Lima GH, Forjaz CL, et al. Impact of a supervised strength training or walking training over a subsequent unsupervised therapy period on walking capacity in patients with claudication. J Vasc Nurs. 2011;29(2):81–86. doi: 10.1016/j.jvn.2011.01.002. [DOI] [PubMed] [Google Scholar]
- 53.Parr BM, Noakes TD, Derman EW. Peripheral arterial disease and intermittent claudication: Efficacy of short-term upper body strength training, dynamic exercise training, and advice to exercise at home. S Afr Med J. 2009;99(11):800–804. [PubMed] [Google Scholar]
- 54.Ritti-Dias RM, Wolosker N, de Moraes Forjaz CL, et al. Strength training increases walking tolerance in intermittent claudication patients: Randomized trial. J Vasc Surg. 2010;51(1):89–95. doi: 10.1016/j.jvs.2009.07.118. [DOI] [PubMed] [Google Scholar]
- 55.Wang E, Helgerud J, Loe H, et al. Maximal strength training improves walking performance in peripheral arterial disease patients. Scand J Med Sci Sports. 2010;20(5):764–770. doi: 10.1111/j.1600-0838.2009.01014.x. [DOI] [PubMed] [Google Scholar]
- 56.Regensteiner JG, Stewart KJ. Established and evolving medical therapies for claudication in patients with peripheral arterial disease. Nat Clin Pract Cardiovasc Med. 2006;3(11):604–610. doi: 10.1038/ncpcardio0660. [DOI] [PubMed] [Google Scholar]
- 57.Frank L, Engelke P, Schmid T. Health and Community Design. The Impact of the Built Environment on Physical Activity. Washington D.C.: Island Press; 2003. [Google Scholar]
- 58.Weiss BD. Clinical syndromes associated with bicycle seats. Clin Sports Med. 1994;13(1):175–186. [PubMed] [Google Scholar]
- 59.Schwameder H, Roithner R, Muller E, et al. Knee joint forces during downhill walking with hiking poles. J Sports Sci. 1999;17(12):969–978. doi: 10.1080/026404199365362. [DOI] [PubMed] [Google Scholar]